$13.21
-0.190 (-1.42%)
At Close: Jun 22, 2026
InMode Appoints Michael Dennison as President of North America
08:05am, Monday, 03'rd Nov 2025
IRVINE, Calif. , Nov. 3, 2025 /PRNewswire/ -- InMode Ltd.
InMode to Participate in Upcoming Investor Conferences
08:30am, Thursday, 30'th Oct 2025
YOKNEAM, Israel , Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor co
D.A. Davidson & CO. Sells 1,376 Shares of InMode Ltd. $INMD
04:00am, Wednesday, 29'th Oct 2025
D.A. Davidson and CO. reduced its position in InMode Ltd. (NASDAQ: INMD) by 2.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Com
InMode: Discounted Valuation & Strong Fundamentals Make It A Buy
02:07pm, Monday, 27'th Oct 2025
InMode presents an appealing buy opportunity, trading near 52-week lows with strong fundamentals, innovative technology, and global expansion. INMD's minimally invasive platforms drive revenue growth,
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd.
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders
08:15am, Tuesday, 09'th Sep 2025
Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026 Maintains Board Has Legal and Fiduciary Duty to Act in Best Interests of Shareholders MIAMI
InMode to Present at Baird 2025 Global Healthcare Conference
08:30am, Tuesday, 02'nd Sep 2025
YOKNEAM, Israel , Sept. 2, 2025 /PRNewswire/ -- InMode Ltd.
InMode to Participate in Upcoming Investor Conferences
08:30am, Tuesday, 05'th Aug 2025
YOKNEAM, Israel , Aug. 5, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor con
InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript
03:22pm, Wednesday, 30'th Jul 2025
InMode Ltd. (NASDAQ:INMD ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Cal
InMode (INMD) Q2 Earnings and Revenues Beat Estimates
09:11am, Wednesday, 30'th Jul 2025
InMode (INMD) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.34 per share a year ago.
InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins
07:00am, Wednesday, 30'th Jul 2025
YOKNEAM, Israel, July 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results f
InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Wednesday, 23'rd Jul 2025
InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InMode: Margin Pressure, But Optionality Makes It Worth A Look
08:08am, Saturday, 12'th Jul 2025
InMode's fundamentals remain strong despite guidance cuts, macro headwinds, and governance disputes, making current negative sentiment appear overdone. Valuation is compelling at just 9.3x forward EPS
Conference call to be held on Wednesday, July 30, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, July 10, 2025 /PRNewswire/ -- InMode Ltd.
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
08:30am, Wednesday, 28'th May 2025
YOKNEAM, Israel , May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capital Manage
Sign In
Buy INMD